Variant #0000987803 (NC_000017.10:g.3563595_3563606del, NM_001031681.2:c.1036_1047del (CTNS))
Individual ID |
00451648 |
Chromosome |
17 |
Allele |
Paternal (confirmed) |
Affects function (as reported) |
Probably affects function |
Affects function (by curator) |
Not classified |
Classification method |
ACMG |
Clinical classification |
likely pathogenic (recessive) |
DNA change (genomic) (Relative to hg19 / GRCh37) |
g.3563595_3563606del |
DNA change (hg38) |
g.3660301_3660312del |
Published as |
- |
ISCN |
- |
DB-ID |
CTNS_000079 |
Variant remarks |
Variant classified as per ACMG guidelines (Richards et al 2015) and to the recently developed ACMG scoring system (Tavtigian et al 2020). This variant that is responsible of 'Cystinosis, nephropathic', was identified in co-occurrence with the COL4A5 heterozygous pathogenic variant NM_033380.3:c.3088G>A, p.Gly1030Ser, causing Alport syndrome 1. This variant was confirmed by Sanger sequencing in patient and tested in parents (paternal confirmed) |
Reference |
- |
ClinVar ID |
- |
dbSNP ID |
rs771552404 |
Origin |
Germline |
Segregation |
yes |
Frequency |
- |
Re-site |
- |
VIP |
- |
Methylation |
- |
Average frequency (gnomAD v.2.1.1) |
Retrieve |
Owner |
Miriam Erandi Reyna-Fabián |
Database submission license |
Creative Commons Attribution-ShareAlike 4.0 International |
Created by |
Miriam Erandi Reyna-Fabián |
Date created |
2024-06-20 21:20:11 +02:00 (CEST) |
Date last edited |
2024-06-28 10:31:43 +02:00 (CEST) |

Variant on transcripts
Screenings
|